Centro de Pesquisas Clínicas em Oncologia

Cachoeiro de Itapemirim, Espírito Santo 29308-014

1 studies enrolling now · 2 studies all time

What they study most

BRAF V600E-mutant Metastatic Colorectal Cancer, Breast Cancer

Studies at this site

• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer — Completed